Diagnostic value of a group of miRNA genes hypermethylated in non-small cell lung cancer
Abstract
The high mortality in non-small cell lung cancer (NSCLC) and the lack of effective diagnostics indicate a need for new NSCLC biomarkers. Epigenomic studies have shown that the proportion of hypermethylated miRNA genes is several times higher than of protein-coding genes, which makes them promising markers. The aim of the study was to evaluate diagnostic characteristics of a group of hypermethylated miRNA genes in NSCLC and its subtypes, squamous cell lung cancer (SLC), and adenocarcinoma (AC). On a set of 39 NSCLC samples and 20 samples of lung tissue from «donors» (dead from non-oncological disease), methylation-specific PCR was used to perform a comparative analysis of methylation of a group of genes, MIR-125B-1, MIR-129-2, MIR-137, and MIR -375. The ROC-analysis identified 6 potential diagnostic systems of markers for NSCLC, SLC, and AC, which had high sensitivity (85—92%) and specificity (90—95%) and the AUC value of 0.89—0.94. The diagnostic systems for SLC and NSCLC showed the best values.